Cover Image
Market Research Report
Product code 
1102148

Global Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Route of Administration, By Synthesis Technology, By Type of Manufacturers, By Application, By Regional Outlook and Forecast, 2022 - 2028

Published: | KBV Research | 343 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Route of Administration, By Synthesis Technology, By Type of Manufacturers, By Application, By Regional Outlook and Forecast, 2022 - 2028
Published: June 30, 2022
KBV Research
Content info: 343 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Global Peptide Therapeutics Market size is expected to reach $58.4 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.

Peptide therapeutics are polypeptides or peptides (oligomers or short polymers of amino acids) that are utilized to treat disorders. Peptide treatments replicate natural peptide functions such as hormones, neurotransmitters, growth factors, ion channel ligands, and anti-infectives. Because peptides may be digested by the body, they are thought to be reasonably safe and well-tolerated.

Liraglutide, the most popular diabetic medicine on the market, contains a lipid chain that increases plasma circulation and provides long-term absorption. Liraglutide is a GLP-1 agonist that self-assembles itself into an alpha-helical structure and only needs to be consumed once a day. Liraglutide's half-life in the blood is lengthened by approximately 13-14 hours due to lipid conjugation of a palmitoyl chain to a lysine residue at position 26. This is attributed to the palmitoyl chain's ability to bind albumin non-covalently, delaying DPP IV's proteolytic action and enabling fast renal clearance. The inclusion of the lipid chain could further extend the half-life by preventing the DPP IV enzyme from degrading sterically.

Lanreotide, an octapeptide, is another peptide that may self-assemble. This medication is a synthetic counterpart of the peptide hormone somatostatin, which is used to alleviate acromegaly (a malfunction where the body produced excessive amounts of growth hormone). Lanreotide assembles itself into monodisperse liquid crystalline nanotubes when exposed to water. The nanotubes are composed of dimers that self-assemble into a 2D lattice that is kept together by antiparallel B-sheets and lateral chain connections. Studies on self-assembling amyloid aggregates created by peptide hormones and neuropeptides have provided more insight into how self-assembly, as well as peptide hormones, are connected.

COVID-19 Impact

COVID-19 was addressed using novel peptides that have been repurposed as medicines. Researchers throughout the world are still looking for chemicals that can either stop SARS-CoV-2 infection and replication or relieve symptoms caused by the virus. The FDA revised its definition of a biologic to include chemically produced polypeptides with a length of more than 40 amino acids but less than 100 amino acids (synthetic proteins) and synthetic peptides with a length of 40 amino acids or less (synthetic peptides). There were 21 peptide medicines in development for the treatment of COVID-19, including 15 synthetic peptides in therapies for the treatment of ARDS and other respiratory disorders caused by SARS-Cov-2 infection.

Market Growth Factors

Rising number of applications

Cardiovascular disease (CVD) is still the major cause of death and morbidity around the world. Many interventions are being tested to ameliorate pathological cardiovascular problems, however, there have been few new drugs licensed for intervention or treatment. As a result, novel techniques for treating CVD are urgently needed. The treatment of contributory risk factors and underlying mechanisms, such as inflammation, obesity, hyperglycemia, and hypercholesterolemia is frequently used to prevent vascular problems. The pharmaceutical industry has traditionally resisted using peptides as therapeutic agents due to their limited stability, size, rate of breakdown, and poor distribution. However, there has been a renaissance in the development of peptides and their synthetic derivatives for therapeutic intervention in recent years.

Increasing cases of cancer all over the world

Cancer is the second leading cause of death, accounting for a considerable number of deaths all over the world in 2013. The rate of cancer in developed countries is significantly higher than in developing countries. The prevalence of known risk factors is predicted to rise in these under-developed nations due to population growth and aging, as well as an increased prevalence of known risk factors. Lung cancer is the largest cause of death from cancer in men around the world, but only in industrialized countries, while breast cancer is the leading reason of cancer death in developing countries. Somatic gene mutations that change the function of the proteins they encode have been linked to cancer. Most solid tumors, like those of the brain, colon, breast, and pancreas, exhibit somatic changes.

Market Restraining Factors

Side effects and risks related to peptide therapy

Natural polypeptides like hormones, growth factors, and neurotransmitters, unlike synthesized peptide medications, are considered to play an important function in normal physiology. Membrane impermeability and in vivo instability are two key disadvantages of peptide medicines. Proteolytic degradation of peptide medicines in serum diminishes the bioavailable concentration and reduces the drug's half-life. To keep the medicine at a clinically effective concentration, routine dosing may be required. To avoid proteolytic degradation and enhance the in vivo half-life of peptide medicines, a variety of chemical modification approaches have been used.

Type Outlook

Based on Type, the market is segmented into Innovative and Generic. In 2021, the innovative segment procured the highest revenue share of the peptide therapeutics market. The constantly rising growth of the segment is owing to significant R&D investments by major pharmaceutical companies in the development of newer pharmaceuticals and high prescription rates. Based on kind, the market is segmented into generic and inventive categories.

Route of Administration Outlook

Based on Route of Administration, the market is segmented into Parenteral Route, Pulmonary, Mucosal, Oral Route, and Others. In 2021, the pulmonary segment registered a significant revenue share of the peptide therapeutics market. The pulmonary route is recognized for peptide and protein delivery because of the physiological properties of the respiratory system. Numerous proteins and peptides are now being tested in clinical studies and are seeking authorization for use in the lungs.

Synthesis Technology Outlook

Based on Synthesis Technology, the market is segmented into Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), and Hybrid Technology. In 2021, the Liquid Phase Peptide Synthesis segment recorded the highest revenue share of the peptide therapeutics market. The expediting growth of the segment is owing to the increased need for pure peptides for the development of effective medicines. Consumer preferences are evolving to quicker and more accurate approaches such as LPPS as a result of challenges such as greater time consumption. Hence, the growth of the segment is flourishing.

Type of Manufacturers Outlook

Based on Type of Manufacturers, the market is segmented into In-house and Outsourced. In 2021, the outsourcing segment recorded a significant revenue share of the peptide therapeutics market. The growth of the segment is rising due to the challenges in developing therapeutics that meet high-quality standards. Businesses choose to outsource the Active Pharmaceutical Ingredient (API) to companies with advanced technology and expertise in the production of peptides of various sorts.

Application Outlook

Based on Application, the market is segmented into Metabolic, Cardiovascular Disorder, GIT & Renal, Antiinfection & Dermatology, Respiratory, Central Nervous System, Cancer, Pain, and Others. In 2021, the metabolic segment acquired the largest revenue share of the peptide therapeutics market. The increasing growth of the segment is attributed to the fact that metabolic problems are becoming increasingly common. These problems have become more common as a result of sedentism, bad eating habits, and excessive alcohol usage. Furthermore, the market is likely to benefit from the growing geriatric population, which is sensitive to metabolic problems.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, North America accounted for the highest revenue share of the peptide therapeutics market. The growing awareness of peptide treatments, rising demand for cancer and other disease diagnostics, and the burgeoning biotechnology industry are all contributing to the growth of the regional market. Peptide therapies are also likely to benefit from growing government R&D spending throughout the coming years. The well-established pharmaceutical and biopharmaceutical industry in this region is a primary driver of growth.

The major strategies followed by the market participants are Partnerships and Approvals. Based on the Analysis presented in the Cardinal matrix; Pfizer, Inc. and Novartis AG are the forerunner in the Peptide Therapeutics Market. Companies such as Eli Lilly And Company, Sanofi S.A. and Takeda Pharmaceutical Company Limited are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, AstraZeneca PLC, Teva Pharmaceuticals Industries Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Lonza Group AG, and Amgen, Inc.

Recent Strategies deployed in Peptide Therapeutics Market

Partnerships, Collaborations and Agreements:

Mar-2022: Sanofi partnered with Adagene, a platform-driven, clinical-stage biopharmaceutical company. Under this partnership, the companies would manufacture and commercialize masked monoclonal and bispecific antibodies in order to introduce transformative novel medicines to cancer patients all over the world.

Jan-2022: Amgen joined hands with Generate Biomedicinesm, a therapeutics company. Under this collaboration, the companies would focus on the discovery and development of protein therapy for five clinical targets within certain therapeutic areas as well as multiple modalities.

Dec-2021: Eli Lilly and Company came into a multi-year research collaboration and licensing agreement with Regor Therapeutics Group, a clinical-stage company. Under this agreement, the companies would discover, manufacture, and commercialize new therapies to cure metabolic disorders. Moreover, Regor's technology would also enable Eli Lilly to drive innovation and offer breakthrough therapies for diabetes and obesity.

Jul-2021: Takeda Pharmaceutical Company teamed up with PeptiDream, a biopharmaceutical company. Following this partnership, the companies would develop peptide-drug conjugates for certain central nervous system targets, which cause chronic neurodegenerative diseases.

Jul-2020: AstraZeneca entered into an agreement with Daiichi Sankyo Company, an innovative global healthcare company. Following this agreement, the companies aimed to expand the reach of the DS-1062 to more patients all over the world in a shorter period of time.

Product Launches and Product Expansions:

Apr-2020: Teva Pharmaceuticals released the autoinjector device for AJOVY. With this launch, the company aimed to offer preventive treatment for migraine to adult patients. Moreover, the new product is the only anti-CGRP preventive migraine treatment.

Acquisitions and Mergers:

May-2022: Pfizer took over Biohaven Pharmaceutical, a commercial-stage biopharmaceutical company. Following this acquisition, the company aimed to incorporate Biohaven's Rimegepant and Zavegepant along with an offering of five pre-clinical CGRP assets.

Jul-2021: Eli Lilly and Company completed its acquisition of Protomer Technologies, a biotech company. With this acquisition, the company aimed to integrate the glucose-sensing insulin program of Protomer Technologies into its portfolio in order to strengthen its offerings. In addition, Eli Lilly would enhance the diabetes lineup of Protomer with the company's innovative technology

Sep-2020: AstraZeneca acquired the preclinical oral PCSK9 inhibitor program of Dogma Therapeutics, an operator of a biotechnology platform. Following this acquisition, the company aimed to advance the program into the clinical development for dyslipidemia and familial hypercholesterolemia.

Approvals and Trails:

May-2022: Eli Lilly and Company received the US FDA approval for its Mounjaro injection. The novel once-weekly GIP and GLP-1 receptors agonist are approved as an adjunct to exercise and diet in order to enhance glycemic control within adults with type 2 diabetes.

Mar-2022: Novartis received the US FDA approval for its Pluvicto. Through this approval, the company aimed to offer a treatment to adult patients with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer, a type of advanced cancer. In addition, Pluvicto is the first radioligand therapy approved by the US FDA that incorporates a therapeutic radioisotope and a targeting compound.

Sep-2021: Teva Pharmaceuticals and MedinCell received the US FDA approval for their TV-46000/mdc-IRM. The new product is approved on the basis of the RISE Study and SHINE Study, two Phase III clinical trials, for the treatment of schizophrenia.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Innovative
  • Generic

By Route of Administration

  • Parenteral Route
  • Pulmonary
  • Mucosal
  • Oral Route
  • Others

By Synthesis Technology

  • Liquid Phase Peptide Synthesis (LPPS)
  • Solid Phase Peptide Synthesis (SPPS)
  • Hybrid Technology

By Type of Manufacturers

  • In-house
  • Outsourced

By Application

  • Metabolic
  • Cardiovascular Disorder
  • GIT & Renal
  • Antiinfection & Dermatology
  • Respiratory
  • Central Nervous System
  • Cancer
  • Pain
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Eli Lilly And Company
  • AstraZeneca PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Takeda Pharmaceutical Company Limited
  • Lonza Group AG
  • Amgen, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.1 Objectives
  • 1.2 Market Scope
  • 1.3 Segmentation
    • 1.3.1 Global Peptide Therapeutics Market, by Type
    • 1.3.2 Global Peptide Therapeutics Market, by Route of Administration
    • 1.3.3 Global Peptide Therapeutics Market, by Synthesis Technology
    • 1.3.4 Global Peptide Therapeutics Market, by Type of Manufacturers
    • 1.3.5 Global Peptide Therapeutics Market, by Application
    • 1.3.6 Global Peptide Therapeutics Market, by Geography
  • 1.4 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Approvals and Trails
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Peptide Therapeutics Market by Type

  • 4.1 Global Innovative Market by Region
  • 4.2 Global Generic Market by Region

Chapter 5. Global Peptide Therapeutics Market by Route of Administration

  • 5.1 Global Parenteral Route Market by Region
  • 5.2 Global Pulmonary Market by Region
  • 5.3 Global Mucosal Market by Region
  • 5.4 Global Oral Route Market by Region
  • 5.5 Global Others Market by Region

Chapter 6. Global Peptide Therapeutics Market by Synthesis Technology

  • 6.1 Global Liquid Phase Peptide Synthesis (LPPS) Market by Region
  • 6.2 Global Solid Phase Peptide Synthesis (SPPS) Market by Region
  • 6.3 Global Hybrid Technology Market by Region

Chapter 7. Global Peptide Therapeutics Market by Type of Manufacturers

  • 7.1 Global In-house Market by Region
  • 7.2 Global Outsourced Market by Region

Chapter 8. Global Peptide Therapeutics Market by Application

  • 8.1 Global Metabolic Market by Region
  • 8.2 Global Cardiovascular Disorder Market by Region
  • 8.3 Global GIT & Renal Market by Region
  • 8.4 Global Antiinfection & Dermatology Market by Region
  • 8.5 Global Respiratory Market by Region
  • 8.6 Global Central Nervous System Market by Region
  • 8.7 Global Cancer Market by Region
  • 8.8 Global Pain Market by Region
  • 8.9 Global Others Market by Region

Chapter 9. Global Peptide Therapeutics Market by Region

  • 9.1 North America Peptide Therapeutics Market
    • 9.1.1 North America Peptide Therapeutics Market by Type
      • 9.1.1.1 North America Innovative Market by Country
      • 9.1.1.2 North America Generic Market by Country
    • 9.1.2 North America Peptide Therapeutics Market by Route of Administration
      • 9.1.2.1 North America Parenteral Route Market by Country
      • 9.1.2.2 North America Pulmonary Market by Country
      • 9.1.2.3 North America Mucosal Market by Country
      • 9.1.2.4 North America Oral Route Market by Country
      • 9.1.2.5 North America Others Market by Country
    • 9.1.3 North America Peptide Therapeutics Market by Synthesis Technology
      • 9.1.3.1 North America Liquid Phase Peptide Synthesis (LPPS) Market by Country
      • 9.1.3.2 North America Solid Phase Peptide Synthesis (SPPS) Market by Country
      • 9.1.3.3 North America Hybrid Technology Market by Country
    • 9.1.4 North America Peptide Therapeutics Market by Type of Manufacturers
      • 9.1.4.1 North America In-house Market by Country
      • 9.1.4.2 North America Outsourced Market by Country
    • 9.1.5 North America Peptide Therapeutics Market by Application
      • 9.1.5.1 North America Metabolic Market by Country
      • 9.1.5.2 North America Cardiovascular Disorder Market by Country
      • 9.1.5.3 North America GIT & Renal Market by Country
      • 9.1.5.4 North America Antiinfection & Dermatology Market by Country
      • 9.1.5.5 North America Respiratory Market by Country
      • 9.1.5.6 North America Central Nervous System Market by Country
      • 9.1.5.7 North America Cancer Market by Country
      • 9.1.5.8 North America Pain Market by Country
      • 9.1.5.9 North America Others Market by Country
    • 9.1.6 North America Peptide Therapeutics Market by Country
      • 9.1.6.1 US Peptide Therapeutics Market
        • 9.1.6.1.1 US Peptide Therapeutics Market by Type
        • 9.1.6.1.2 US Peptide Therapeutics Market by Route of Administration
        • 9.1.6.1.3 US Peptide Therapeutics Market by Synthesis Technology
        • 9.1.6.1.4 US Peptide Therapeutics Market by Type of Manufacturers
        • 9.1.6.1.5 US Peptide Therapeutics Market by Application
      • 9.1.6.2 Canada Peptide Therapeutics Market
        • 9.1.6.2.1 Canada Peptide Therapeutics Market by Type
        • 9.1.6.2.2 Canada Peptide Therapeutics Market by Route of Administration
        • 9.1.6.2.3 Canada Peptide Therapeutics Market by Synthesis Technology
        • 9.1.6.2.4 Canada Peptide Therapeutics Market by Type of Manufacturers
        • 9.1.6.2.5 Canada Peptide Therapeutics Market by Application
      • 9.1.6.3 Mexico Peptide Therapeutics Market
        • 9.1.6.3.1 Mexico Peptide Therapeutics Market by Type
        • 9.1.6.3.2 Mexico Peptide Therapeutics Market by Route of Administration
        • 9.1.6.3.3 Mexico Peptide Therapeutics Market by Synthesis Technology
        • 9.1.6.3.4 Mexico Peptide Therapeutics Market by Type of Manufacturers
        • 9.1.6.3.5 Mexico Peptide Therapeutics Market by Application
      • 9.1.6.4 Rest of North America Peptide Therapeutics Market
        • 9.1.6.4.1 Rest of North America Peptide Therapeutics Market by Type
        • 9.1.6.4.2 Rest of North America Peptide Therapeutics Market by Route of Administration
        • 9.1.6.4.3 Rest of North America Peptide Therapeutics Market by Synthesis Technology
        • 9.1.6.4.4 Rest of North America Peptide Therapeutics Market by Type of Manufacturers
        • 9.1.6.4.5 Rest of North America Peptide Therapeutics Market by Application
  • 9.2 Europe Peptide Therapeutics Market
    • 9.2.1 Europe Peptide Therapeutics Market by Type
      • 9.2.1.1 Europe Innovative Market by Country
      • 9.2.1.2 Europe Generic Market by Country
    • 9.2.2 Europe Peptide Therapeutics Market by Route of Administration
      • 9.2.2.1 Europe Parenteral Route Market by Country
      • 9.2.2.2 Europe Pulmonary Market by Country
      • 9.2.2.3 Europe Mucosal Market by Country
      • 9.2.2.4 Europe Oral Route Market by Country
      • 9.2.2.5 Europe Others Market by Country
    • 9.2.3 Europe Peptide Therapeutics Market by Synthesis Technology
      • 9.2.3.1 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country
      • 9.2.3.2 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country
      • 9.2.3.3 Europe Hybrid Technology Market by Country
    • 9.2.4 Europe Peptide Therapeutics Market by Type of Manufacturers
      • 9.2.4.1 Europe In-house Market by Country
      • 9.2.4.2 Europe Outsourced Market by Country
    • 9.2.5 Europe Peptide Therapeutics Market by Application
      • 9.2.5.1 Europe Metabolic Market by Country
      • 9.2.5.2 Europe Cardiovascular Disorder Market by Country
      • 9.2.5.3 Europe GIT & Renal Market by Country
      • 9.2.5.4 Europe Antiinfection & Dermatology Market by Country
      • 9.2.5.5 Europe Respiratory Market by Country
      • 9.2.5.6 Europe Central Nervous System Market by Country
      • 9.2.5.7 Europe Cancer Market by Country
      • 9.2.5.8 Europe Pain Market by Country
      • 9.2.5.9 Europe Others Market by Country
    • 9.2.6 Europe Peptide Therapeutics Market by Country
      • 9.2.6.1 Germany Peptide Therapeutics Market
        • 9.2.6.1.1 Germany Peptide Therapeutics Market by Type
        • 9.2.6.1.2 Germany Peptide Therapeutics Market by Route of Administration
        • 9.2.6.1.3 Germany Peptide Therapeutics Market by Synthesis Technology
        • 9.2.6.1.4 Germany Peptide Therapeutics Market by Type of Manufacturers
        • 9.2.6.1.5 Germany Peptide Therapeutics Market by Application
      • 9.2.6.2 UK Peptide Therapeutics Market
        • 9.2.6.2.1 UK Peptide Therapeutics Market by Type
        • 9.2.6.2.2 UK Peptide Therapeutics Market by Route of Administration
        • 9.2.6.2.3 UK Peptide Therapeutics Market by Synthesis Technology
        • 9.2.6.2.4 UK Peptide Therapeutics Market by Type of Manufacturers
        • 9.2.6.2.5 UK Peptide Therapeutics Market by Application
      • 9.2.6.3 France Peptide Therapeutics Market
        • 9.2.6.3.1 France Peptide Therapeutics Market by Type
        • 9.2.6.3.2 France Peptide Therapeutics Market by Route of Administration
        • 9.2.6.3.3 France Peptide Therapeutics Market by Synthesis Technology
        • 9.2.6.3.4 France Peptide Therapeutics Market by Type of Manufacturers
        • 9.2.6.3.5 France Peptide Therapeutics Market by Application
      • 9.2.6.4 Russia Peptide Therapeutics Market
        • 9.2.6.4.1 Russia Peptide Therapeutics Market by Type
        • 9.2.6.4.2 Russia Peptide Therapeutics Market by Route of Administration
        • 9.2.6.4.3 Russia Peptide Therapeutics Market by Synthesis Technology
        • 9.2.6.4.4 Russia Peptide Therapeutics Market by Type of Manufacturers
        • 9.2.6.4.5 Russia Peptide Therapeutics Market by Application
      • 9.2.6.5 Spain Peptide Therapeutics Market
        • 9.2.6.5.1 Spain Peptide Therapeutics Market by Type
        • 9.2.6.5.2 Spain Peptide Therapeutics Market by Route of Administration
        • 9.2.6.5.3 Spain Peptide Therapeutics Market by Synthesis Technology
        • 9.2.6.5.4 Spain Peptide Therapeutics Market by Type of Manufacturers
        • 9.2.6.5.5 Spain Peptide Therapeutics Market by Application
      • 9.2.6.6 Italy Peptide Therapeutics Market
        • 9.2.6.6.1 Italy Peptide Therapeutics Market by Type
        • 9.2.6.6.2 Italy Peptide Therapeutics Market by Route of Administration
        • 9.2.6.6.3 Italy Peptide Therapeutics Market by Synthesis Technology
        • 9.2.6.6.4 Italy Peptide Therapeutics Market by Type of Manufacturers
        • 9.2.6.6.5 Italy Peptide Therapeutics Market by Application
      • 9.2.6.7 Rest of Europe Peptide Therapeutics Market
        • 9.2.6.7.1 Rest of Europe Peptide Therapeutics Market by Type
        • 9.2.6.7.2 Rest of Europe Peptide Therapeutics Market by Route of Administration
        • 9.2.6.7.3 Rest of Europe Peptide Therapeutics Market by Synthesis Technology
        • 9.2.6.7.4 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers
        • 9.2.6.7.5 Rest of Europe Peptide Therapeutics Market by Application
  • 9.3 Asia Pacific Peptide Therapeutics Market
    • 9.3.1 Asia Pacific Peptide Therapeutics Market by Type
      • 9.3.1.1 Asia Pacific Innovative Market by Country
      • 9.3.1.2 Asia Pacific Generic Market by Country
    • 9.3.2 Asia Pacific Peptide Therapeutics Market by Route of Administration
      • 9.3.2.1 Asia Pacific Parenteral Route Market by Country
      • 9.3.2.2 Asia Pacific Pulmonary Market by Country
      • 9.3.2.3 Asia Pacific Mucosal Market by Country
      • 9.3.2.4 Asia Pacific Oral Route Market by Country
      • 9.3.2.5 Asia Pacific Others Market by Country
    • 9.3.3 Asia Pacific Peptide Therapeutics Market by Synthesis Technology
      • 9.3.3.1 Asia Pacific Liquid Phase Peptide Synthesis (LPPS) Market by Country
      • 9.3.3.2 Asia Pacific Solid Phase Peptide Synthesis (SPPS) Market by Country
      • 9.3.3.3 Asia Pacific Hybrid Technology Market by Country
    • 9.3.4 Asia Pacific Peptide Therapeutics Market by Type of Manufacturers
      • 9.3.4.1 Asia Pacific In-house Market by Country
      • 9.3.4.2 Asia Pacific Outsourced Market by Country
    • 9.3.5 Asia Pacific Peptide Therapeutics Market by Application
      • 9.3.5.1 Asia Pacific Metabolic Market by Country
      • 9.3.5.2 Asia Pacific Cardiovascular Disorder Market by Country
      • 9.3.5.3 Asia Pacific GIT & Renal Market by Country
      • 9.3.5.4 Asia Pacific Antiinfection & Dermatology Market by Country
      • 9.3.5.5 Asia Pacific Respiratory Market by Country
      • 9.3.5.6 Asia Pacific Central Nervous System Market by Country
      • 9.3.5.7 Asia Pacific Cancer Market by Country
      • 9.3.5.8 Asia Pacific Pain Market by Country
      • 9.3.5.9 Asia Pacific Others Market by Country
    • 9.3.6 Asia Pacific Peptide Therapeutics Market by Country
      • 9.3.6.1 China Peptide Therapeutics Market
        • 9.3.6.1.1 China Peptide Therapeutics Market by Type
        • 9.3.6.1.2 China Peptide Therapeutics Market by Route of Administration
        • 9.3.6.1.3 China Peptide Therapeutics Market by Synthesis Technology
        • 9.3.6.1.4 China Peptide Therapeutics Market by Type of Manufacturers
        • 9.3.6.1.5 China Peptide Therapeutics Market by Application
      • 9.3.6.2 Japan Peptide Therapeutics Market
        • 9.3.6.2.1 Japan Peptide Therapeutics Market by Type
        • 9.3.6.2.2 Japan Peptide Therapeutics Market by Route of Administration
        • 9.3.6.2.3 Japan Peptide Therapeutics Market by Synthesis Technology
        • 9.3.6.2.4 Japan Peptide Therapeutics Market by Type of Manufacturers
        • 9.3.6.2.5 Japan Peptide Therapeutics Market by Application
      • 9.3.6.3 India Peptide Therapeutics Market
        • 9.3.6.3.1 India Peptide Therapeutics Market by Type
        • 9.3.6.3.2 India Peptide Therapeutics Market by Route of Administration
        • 9.3.6.3.3 India Peptide Therapeutics Market by Synthesis Technology
        • 9.3.6.3.4 India Peptide Therapeutics Market by Type of Manufacturers
        • 9.3.6.3.5 India Peptide Therapeutics Market by Application
      • 9.3.6.4 South Korea Peptide Therapeutics Market
        • 9.3.6.4.1 South Korea Peptide Therapeutics Market by Type
        • 9.3.6.4.2 South Korea Peptide Therapeutics Market by Route of Administration
        • 9.3.6.4.3 South Korea Peptide Therapeutics Market by Synthesis Technology
        • 9.3.6.4.4 South Korea Peptide Therapeutics Market by Type of Manufacturers
        • 9.3.6.4.5 South Korea Peptide Therapeutics Market by Application
      • 9.3.6.5 Singapore Peptide Therapeutics Market
        • 9.3.6.5.1 Singapore Peptide Therapeutics Market by Type
        • 9.3.6.5.2 Singapore Peptide Therapeutics Market by Route of Administration
        • 9.3.6.5.3 Singapore Peptide Therapeutics Market by Synthesis Technology
        • 9.3.6.5.4 Singapore Peptide Therapeutics Market by Type of Manufacturers
        • 9.3.6.5.5 Singapore Peptide Therapeutics Market by Application
      • 9.3.6.6 Malaysia Peptide Therapeutics Market
        • 9.3.6.6.1 Malaysia Peptide Therapeutics Market by Type
        • 9.3.6.6.2 Malaysia Peptide Therapeutics Market by Route of Administration
        • 9.3.6.6.3 Malaysia Peptide Therapeutics Market by Synthesis Technology
        • 9.3.6.6.4 Malaysia Peptide Therapeutics Market by Type of Manufacturers
        • 9.3.6.6.5 Malaysia Peptide Therapeutics Market by Application
      • 9.3.6.7 Rest of Asia Pacific Peptide Therapeutics Market
        • 9.3.6.7.1 Rest of Asia Pacific Peptide Therapeutics Market by Type
        • 9.3.6.7.2 Rest of Asia Pacific Peptide Therapeutics Market by Route of Administration
        • 9.3.6.7.3 Rest of Asia Pacific Peptide Therapeutics Market by Synthesis Technology
        • 9.3.6.7.4 Rest of Asia Pacific Peptide Therapeutics Market by Type of Manufacturers
        • 9.3.6.7.5 Rest of Asia Pacific Peptide Therapeutics Market by Application
  • 9.4 LAMEA Peptide Therapeutics Market
    • 9.4.1 LAMEA Peptide Therapeutics Market by Type
      • 9.4.1.1 LAMEA Innovative Market by Country
      • 9.4.1.2 LAMEA Generic Market by Country
    • 9.4.2 LAMEA Peptide Therapeutics Market by Route of Administration
      • 9.4.2.1 LAMEA Parenteral Route Market by Country
      • 9.4.2.2 LAMEA Pulmonary Market by Country
      • 9.4.2.3 LAMEA Mucosal Market by Country
      • 9.4.2.4 LAMEA Oral Route Market by Country
      • 9.4.2.5 LAMEA Others Market by Country
    • 9.4.3 LAMEA Peptide Therapeutics Market by Synthesis Technology
      • 9.4.3.1 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country
      • 9.4.3.2 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country
      • 9.4.3.3 LAMEA Hybrid Technology Market by Country
    • 9.4.4 LAMEA Peptide Therapeutics Market by Type of Manufacturers
      • 9.4.4.1 LAMEA In-house Market by Country
      • 9.4.4.2 LAMEA Outsourced Market by Country
    • 9.4.5 LAMEA Peptide Therapeutics Market by Application
      • 9.4.5.1 LAMEA Metabolic Market by Country
      • 9.4.5.2 LAMEA Cardiovascular Disorder Market by Country
      • 9.4.5.3 LAMEA GIT & Renal Market by Country
      • 9.4.5.4 LAMEA Antiinfection & Dermatology Market by Country
      • 9.4.5.5 LAMEA Respiratory Market by Country
      • 9.4.5.6 LAMEA Central Nervous System Market by Country
      • 9.4.5.7 LAMEA Cancer Market by Country
      • 9.4.5.8 LAMEA Pain Market by Country
      • 9.4.5.9 LAMEA Others Market by Country
    • 9.4.6 LAMEA Peptide Therapeutics Market by Country
      • 9.4.6.1 Brazil Peptide Therapeutics Market
        • 9.4.6.1.1 Brazil Peptide Therapeutics Market by Type
        • 9.4.6.1.2 Brazil Peptide Therapeutics Market by Route of Administration
        • 9.4.6.1.3 Brazil Peptide Therapeutics Market by Synthesis Technology
        • 9.4.6.1.4 Brazil Peptide Therapeutics Market by Type of Manufacturers
        • 9.4.6.1.5 Brazil Peptide Therapeutics Market by Application
      • 9.4.6.2 Argentina Peptide Therapeutics Market
        • 9.4.6.2.1 Argentina Peptide Therapeutics Market by Type
        • 9.4.6.2.2 Argentina Peptide Therapeutics Market by Route of Administration
        • 9.4.6.2.3 Argentina Peptide Therapeutics Market by Synthesis Technology
        • 9.4.6.2.4 Argentina Peptide Therapeutics Market by Type of Manufacturers
        • 9.4.6.2.5 Argentina Peptide Therapeutics Market by Application
      • 9.4.6.3 UAE Peptide Therapeutics Market
        • 9.4.6.3.1 UAE Peptide Therapeutics Market by Type
        • 9.4.6.3.2 UAE Peptide Therapeutics Market by Route of Administration
        • 9.4.6.3.3 UAE Peptide Therapeutics Market by Synthesis Technology
        • 9.4.6.3.4 UAE Peptide Therapeutics Market by Type of Manufacturers
        • 9.4.6.3.5 UAE Peptide Therapeutics Market by Application
      • 9.4.6.4 Saudi Arabia Peptide Therapeutics Market
        • 9.4.6.4.1 Saudi Arabia Peptide Therapeutics Market by Type
        • 9.4.6.4.2 Saudi Arabia Peptide Therapeutics Market by Route of Administration
        • 9.4.6.4.3 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology
        • 9.4.6.4.4 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers
        • 9.4.6.4.5 Saudi Arabia Peptide Therapeutics Market by Application
      • 9.4.6.5 South Africa Peptide Therapeutics Market
        • 9.4.6.5.1 South Africa Peptide Therapeutics Market by Type
        • 9.4.6.5.2 South Africa Peptide Therapeutics Market by Route of Administration
        • 9.4.6.5.3 South Africa Peptide Therapeutics Market by Synthesis Technology
        • 9.4.6.5.4 South Africa Peptide Therapeutics Market by Type of Manufacturers
        • 9.4.6.5.5 South Africa Peptide Therapeutics Market by Application
      • 9.4.6.6 Nigeria Peptide Therapeutics Market
        • 9.4.6.6.1 Nigeria Peptide Therapeutics Market by Type
        • 9.4.6.6.2 Nigeria Peptide Therapeutics Market by Route of Administration
        • 9.4.6.6.3 Nigeria Peptide Therapeutics Market by Synthesis Technology
        • 9.4.6.6.4 Nigeria Peptide Therapeutics Market by Type of Manufacturers
        • 9.4.6.6.5 Nigeria Peptide Therapeutics Market by Application
      • 9.4.6.7 Rest of LAMEA Peptide Therapeutics Market
        • 9.4.6.7.1 Rest of LAMEA Peptide Therapeutics Market by Type
        • 9.4.6.7.2 Rest of LAMEA Peptide Therapeutics Market by Route of Administration
        • 9.4.6.7.3 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology
        • 9.4.6.7.4 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers
        • 9.4.6.7.5 Rest of LAMEA Peptide Therapeutics Market by Application

Chapter 10. Company Profiles

  • 10.1 Eli Lilly And Company
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Regional Analysis
    • 10.1.4 Research & Development Expenses
    • 10.1.5 Recent strategies and developments:
      • 10.1.5.1 Partnerships, Collaborations, and Agreements:
      • 10.1.5.2 Acquisition and Mergers:
      • 10.1.5.3 Approvals and Trails:
  • 10.2 AstraZeneca PLC
    • 10.2.1 Company Overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Regional Analysis
    • 10.2.4 Research & Development Expenses
    • 10.2.5 Recent strategies and developments:
      • 10.2.5.1 Partnerships, Collaborations, and Agreements:
      • 10.2.5.2 Acquisition and Mergers:
  • 10.3 Teva Pharmaceutical Industries Ltd.
    • 10.3.1 Company Overview
    • 10.3.2 Financial Analysis
    • 10.3.3 Regional Analysis
    • 10.3.4 Research & Development Expenses
    • 10.3.5 Recent strategies and developments:
      • 10.3.5.1 Product Launches and Product Expansions:
      • 10.3.5.2 Approvals and Acquisitions:
  • 10.4 Novartis AG
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Segmental and Regional Analysis
    • 10.4.4 Research & Development Expense
    • 10.4.5 Recent strategies and developments:
      • 10.4.5.1 Acquisition and Mergers:
      • 10.4.5.2 Approvals and Trails:
  • 10.5 Pfizer, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Regional & Segmental Analysis
    • 10.5.4 Research & Development Expense
    • 10.5.5 Recent strategies and developments:
      • 10.5.5.1 Acquisition and Mergers:
  • 10.6 Sanofi S.A.
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Segmental and Regional Analysis
    • 10.6.4 Research & Development Expense
    • 10.6.5 Recent strategies and developments:
      • 10.6.5.1 Partnerships, Collaborations, and Agreements:
  • 10.7 GlaxoSmithKline PLC
    • 10.7.1 Company Overview
    • 10.7.2 Financial Analysis
    • 10.7.3 Segmental and Regional Analysis
    • 10.7.4 Research & Development Expense
  • 10.8 Takeda Pharmaceutical Company Limited
    • 10.8.1 Company Overview
    • 10.8.2 Financial Analysis
    • 10.8.3 Regional Analysis
    • 10.8.4 Research & Development Expense
    • 10.8.5 Recent strategies and developments:
      • 10.8.5.1 Partnerships, Collaborations, and Agreements:
      • 10.8.5.2 Approvals and Trails:
  • 10.9 Lonza Group AG
    • 10.9.1 Company Overview
    • 10.9.2 Financial Analysis
    • 10.9.3 Segmental and Regional Analysis
    • 10.9.4 Research & Development Expenses
  • 10.10. Amgen, Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Financial Analysis
    • 10.10.3 Regional Analysis
    • 10.10.4 Research & Development Expenses
    • 10.10.5 Recent strategies and developments:
      • 10.10.5.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 Global Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 2 Global Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Peptide Therapeutics Market
  • TABLE 4 Acquisition and Mergers- Peptide Therapeutics Market
  • TABLE 5 Approvals and trails- Peptide Therapeutics Market
  • TABLE 6 Global Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 7 Global Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 8 Global Innovative Market by Region, 2018 - 2021, USD Million
  • TABLE 9 Global Innovative Market by Region, 2022 - 2028, USD Million
  • TABLE 10 Global Generic Market by Region, 2018 - 2021, USD Million
  • TABLE 11 Global Generic Market by Region, 2022 - 2028, USD Million
  • TABLE 12 Global Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 13 Global Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 14 Global Parenteral Route Market by Region, 2018 - 2021, USD Million
  • TABLE 15 Global Parenteral Route Market by Region, 2022 - 2028, USD Million
  • TABLE 16 Global Pulmonary Market by Region, 2018 - 2021, USD Million
  • TABLE 17 Global Pulmonary Market by Region, 2022 - 2028, USD Million
  • TABLE 18 Global Mucosal Market by Region, 2018 - 2021, USD Million
  • TABLE 19 Global Mucosal Market by Region, 2022 - 2028, USD Million
  • TABLE 20 Global Oral Route Market by Region, 2018 - 2021, USD Million
  • TABLE 21 Global Oral Route Market by Region, 2022 - 2028, USD Million
  • TABLE 22 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 23 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 24 Global Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 25 Global Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 26 Global Liquid Phase Peptide Synthesis (LPPS) Market by Region, 2018 - 2021, USD Million
  • TABLE 27 Global Liquid Phase Peptide Synthesis (LPPS) Market by Region, 2022 - 2028, USD Million
  • TABLE 28 Global Solid Phase Peptide Synthesis (SPPS) Market by Region, 2018 - 2021, USD Million
  • TABLE 29 Global Solid Phase Peptide Synthesis (SPPS) Market by Region, 2022 - 2028, USD Million
  • TABLE 30 Global Hybrid Technology Market by Region, 2018 - 2021, USD Million
  • TABLE 31 Global Hybrid Technology Market by Region, 2022 - 2028, USD Million
  • TABLE 32 Global Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 33 Global Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 34 Global In-house Market by Region, 2018 - 2021, USD Million
  • TABLE 35 Global In-house Market by Region, 2022 - 2028, USD Million
  • TABLE 36 Global Outsourced Market by Region, 2018 - 2021, USD Million
  • TABLE 37 Global Outsourced Market by Region, 2022 - 2028, USD Million
  • TABLE 38 Global Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 39 Global Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 40 Global Metabolic Market by Region, 2018 - 2021, USD Million
  • TABLE 41 Global Metabolic Market by Region, 2022 - 2028, USD Million
  • TABLE 42 Global Cardiovascular Disorder Market by Region, 2018 - 2021, USD Million
  • TABLE 43 Global Cardiovascular Disorder Market by Region, 2022 - 2028, USD Million
  • TABLE 44 Global GIT & Renal Market by Region, 2018 - 2021, USD Million
  • TABLE 45 Global GIT & Renal Market by Region, 2022 - 2028, USD Million
  • TABLE 46 Global Antiinfection & Dermatology Market by Region, 2018 - 2021, USD Million
  • TABLE 47 Global Antiinfection & Dermatology Market by Region, 2022 - 2028, USD Million
  • TABLE 48 Global Respiratory Market by Region, 2018 - 2021, USD Million
  • TABLE 49 Global Respiratory Market by Region, 2022 - 2028, USD Million
  • TABLE 50 Global Central Nervous System Market by Region, 2018 - 2021, USD Million
  • TABLE 51 Global Central Nervous System Market by Region, 2022 - 2028, USD Million
  • TABLE 52 Global Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 53 Global Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 54 Global Pain Market by Region, 2018 - 2021, USD Million
  • TABLE 55 Global Pain Market by Region, 2022 - 2028, USD Million
  • TABLE 56 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 57 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 58 Global Peptide Therapeutics Market by Region, 2018 - 2021, USD Million
  • TABLE 59 Global Peptide Therapeutics Market by Region, 2022 - 2028, USD Million
  • TABLE 60 North America Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 61 North America Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 62 North America Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 63 North America Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 64 North America Innovative Market by Country, 2018 - 2021, USD Million
  • TABLE 65 North America Innovative Market by Country, 2022 - 2028, USD Million
  • TABLE 66 North America Generic Market by Country, 2018 - 2021, USD Million
  • TABLE 67 North America Generic Market by Country, 2022 - 2028, USD Million
  • TABLE 68 North America Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 69 North America Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 70 North America Parenteral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 71 North America Parenteral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 72 North America Pulmonary Market by Country, 2018 - 2021, USD Million
  • TABLE 73 North America Pulmonary Market by Country, 2022 - 2028, USD Million
  • TABLE 74 North America Mucosal Market by Country, 2018 - 2021, USD Million
  • TABLE 75 North America Mucosal Market by Country, 2022 - 2028, USD Million
  • TABLE 76 North America Oral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 77 North America Oral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 78 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 79 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 80 North America Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 81 North America Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 82 North America Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 83 North America Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 84 North America Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 85 North America Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 86 North America Hybrid Technology Market by Country, 2018 - 2021, USD Million
  • TABLE 87 North America Hybrid Technology Market by Country, 2022 - 2028, USD Million
  • TABLE 88 North America Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 89 North America Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 90 North America In-house Market by Country, 2018 - 2021, USD Million
  • TABLE 91 North America In-house Market by Country, 2022 - 2028, USD Million
  • TABLE 92 North America Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 93 North America Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 94 North America Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 95 North America Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 96 North America Metabolic Market by Country, 2018 - 2021, USD Million
  • TABLE 97 North America Metabolic Market by Country, 2022 - 2028, USD Million
  • TABLE 98 North America Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 99 North America Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 100 North America GIT & Renal Market by Country, 2018 - 2021, USD Million
  • TABLE 101 North America GIT & Renal Market by Country, 2022 - 2028, USD Million
  • TABLE 102 North America Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
  • TABLE 103 North America Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
  • TABLE 104 North America Respiratory Market by Country, 2018 - 2021, USD Million
  • TABLE 105 North America Respiratory Market by Country, 2022 - 2028, USD Million
  • TABLE 106 North America Central Nervous System Market by Country, 2018 - 2021, USD Million
  • TABLE 107 North America Central Nervous System Market by Country, 2022 - 2028, USD Million
  • TABLE 108 North America Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 109 North America Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 110 North America Pain Market by Country, 2018 - 2021, USD Million
  • TABLE 111 North America Pain Market by Country, 2022 - 2028, USD Million
  • TABLE 112 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 113 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 114 North America Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 115 North America Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 116 US Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 117 US Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 118 US Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 119 US Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 120 US Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 121 US Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 122 US Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 123 US Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 124 US Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 125 US Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 126 US Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 127 US Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 128 Canada Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 129 Canada Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 130 Canada Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 131 Canada Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 132 Canada Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 133 Canada Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 134 Canada Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 135 Canada Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 136 Canada Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 137 Canada Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 138 Canada Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 139 Canada Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 140 Mexico Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 141 Mexico Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 142 Mexico Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 143 Mexico Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 144 Mexico Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 145 Mexico Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 146 Mexico Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 147 Mexico Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 148 Mexico Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 149 Mexico Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 150 Mexico Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 151 Mexico Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 152 Rest of North America Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 153 Rest of North America Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 154 Rest of North America Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 155 Rest of North America Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 156 Rest of North America Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 157 Rest of North America Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 158 Rest of North America Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 159 Rest of North America Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 160 Rest of North America Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 161 Rest of North America Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 162 Rest of North America Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 163 Rest of North America Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 164 Europe Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 165 Europe Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 166 Europe Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 167 Europe Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 168 Europe Innovative Market by Country, 2018 - 2021, USD Million
  • TABLE 169 Europe Innovative Market by Country, 2022 - 2028, USD Million
  • TABLE 170 Europe Generic Market by Country, 2018 - 2021, USD Million
  • TABLE 171 Europe Generic Market by Country, 2022 - 2028, USD Million
  • TABLE 172 Europe Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 173 Europe Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 174 Europe Parenteral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 175 Europe Parenteral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 176 Europe Pulmonary Market by Country, 2018 - 2021, USD Million
  • TABLE 177 Europe Pulmonary Market by Country, 2022 - 2028, USD Million
  • TABLE 178 Europe Mucosal Market by Country, 2018 - 2021, USD Million
  • TABLE 179 Europe Mucosal Market by Country, 2022 - 2028, USD Million
  • TABLE 180 Europe Oral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 181 Europe Oral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 182 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 183 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 184 Europe Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 185 Europe Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 186 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 187 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 188 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 189 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 190 Europe Hybrid Technology Market by Country, 2018 - 2021, USD Million
  • TABLE 191 Europe Hybrid Technology Market by Country, 2022 - 2028, USD Million
  • TABLE 192 Europe Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 193 Europe Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 194 Europe In-house Market by Country, 2018 - 2021, USD Million
  • TABLE 195 Europe In-house Market by Country, 2022 - 2028, USD Million
  • TABLE 196 Europe Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 197 Europe Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 198 Europe Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 199 Europe Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 200 Europe Metabolic Market by Country, 2018 - 2021, USD Million
  • TABLE 201 Europe Metabolic Market by Country, 2022 - 2028, USD Million
  • TABLE 202 Europe Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 203 Europe Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 204 Europe GIT & Renal Market by Country, 2018 - 2021, USD Million
  • TABLE 205 Europe GIT & Renal Market by Country, 2022 - 2028, USD Million
  • TABLE 206 Europe Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
  • TABLE 207 Europe Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
  • TABLE 208 Europe Respiratory Market by Country, 2018 - 2021, USD Million
  • TABLE 209 Europe Respiratory Market by Country, 2022 - 2028, USD Million
  • TABLE 210 Europe Central Nervous System Market by Country, 2018 - 2021, USD Million
  • TABLE 211 Europe Central Nervous System Market by Country, 2022 - 2028, USD Million
  • TABLE 212 Europe Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 213 Europe Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 214 Europe Pain Market by Country, 2018 - 2021, USD Million
  • TABLE 215 Europe Pain Market by Country, 2022 - 2028, USD Million
  • TABLE 216 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 217 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 218 Europe Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 219 Europe Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 220 Germany Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 221 Germany Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 222 Germany Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 223 Germany Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 224 Germany Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 225 Germany Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 226 Germany Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 227 Germany Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 228 Germany Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 229 Germany Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 230 Germany Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 231 Germany Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 232 UK Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 233 UK Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 234 UK Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 235 UK Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 236 UK Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 237 UK Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 238 UK Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 239 UK Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 240 UK Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 241 UK Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 242 UK Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 243 UK Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 244 France Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 245 France Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 246 France Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 247 France Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 248 France Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 249 France Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 250 France Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 251 France Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 252 France Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 253 France Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 254 France Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 255 France Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 256 Russia Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 257 Russia Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 258 Russia Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 259 Russia Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 260 Russia Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 261 Russia Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 262 Russia Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 263 Russia Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 264 Russia Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 265 Russia Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 266 Russia Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 267 Russia Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 268 Spain Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 269 Spain Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 270 Spain Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 271 Spain Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 272 Spain Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 273 Spain Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 274 Spain Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 275 Spain Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 276 Spain Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 277 Spain Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 278 Spain Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 279 Spain Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 280 Italy Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 281 Italy Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 282 Italy Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 283 Italy Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 284 Italy Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 285 Italy Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 286 Italy Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 287 Italy Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 288 Italy Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 289 Italy Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 290 Italy Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 291 Italy Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 292 Rest of Europe Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 293 Rest of Europe Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 294 Rest of Europe Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 295 Rest of Europe Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 296 Rest of Europe Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 297 Rest of Europe Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 298 Rest of Europe Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 299 Rest of Europe Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 300 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 301 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 302 Rest of Europe Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 303 Rest of Europe Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 304 Asia Pacific Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 305 Asia Pacific Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 306 Asia Pacific Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 307 Asia Pacific Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 308 Asia Pacific Innovative Market by Country, 2018 - 2021, USD Million
  • TABLE 309 Asia Pacific Innovative Market by Country, 2022 - 2028, USD Million
  • TABLE 310 Asia Pacific Generic Market by Country, 2018 - 2021, USD Million
  • TABLE 311 Asia Pacific Generic Market by Country, 2022 - 2028, USD Million
  • TABLE 312 Asia Pacific Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 313 Asia Pacific Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 314 Asia Pacific Parenteral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 315 Asia Pacific Parenteral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 316 Asia Pacific Pulmonary Market by Country, 2018 - 2021, USD Million
  • TABLE 317 Asia Pacific Pulmonary Market by Country, 2022 - 2028, USD Million
  • TABLE 318 Asia Pacific Mucosal Market by Country, 2018 - 2021, USD Million
  • TABLE 319 Asia Pacific Mucosal Market by Country, 2022 - 2028, USD Million
  • TABLE 320 Asia Pacific Oral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 321 Asia Pacific Oral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 322 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 323 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 324 Asia Pacific Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 325 Asia Pacific Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 326 Asia Pacific Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 327 Asia Pacific Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 328 Asia Pacific Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 329 Asia Pacific Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 330 Asia Pacific Hybrid Technology Market by Country, 2018 - 2021, USD Million
  • TABLE 331 Asia Pacific Hybrid Technology Market by Country, 2022 - 2028, USD Million
  • TABLE 332 Asia Pacific Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 333 Asia Pacific Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 334 Asia Pacific In-house Market by Country, 2018 - 2021, USD Million
  • TABLE 335 Asia Pacific In-house Market by Country, 2022 - 2028, USD Million
  • TABLE 336 Asia Pacific Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 337 Asia Pacific Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 338 Asia Pacific Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 339 Asia Pacific Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 340 Asia Pacific Metabolic Market by Country, 2018 - 2021, USD Million
  • TABLE 341 Asia Pacific Metabolic Market by Country, 2022 - 2028, USD Million
  • TABLE 342 Asia Pacific Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 343 Asia Pacific Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 344 Asia Pacific GIT & Renal Market by Country, 2018 - 2021, USD Million
  • TABLE 345 Asia Pacific GIT & Renal Market by Country, 2022 - 2028, USD Million
  • TABLE 346 Asia Pacific Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
  • TABLE 347 Asia Pacific Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
  • TABLE 348 Asia Pacific Respiratory Market by Country, 2018 - 2021, USD Million
  • TABLE 349 Asia Pacific Respiratory Market by Country, 2022 - 2028, USD Million
  • TABLE 350 Asia Pacific Central Nervous System Market by Country, 2018 - 2021, USD Million
  • TABLE 351 Asia Pacific Central Nervous System Market by Country, 2022 - 2028, USD Million
  • TABLE 352 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 353 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 354 Asia Pacific Pain Market by Country, 2018 - 2021, USD Million
  • TABLE 355 Asia Pacific Pain Market by Country, 2022 - 2028, USD Million
  • TABLE 356 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 357 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 358 Asia Pacific Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 359 Asia Pacific Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 360 China Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 361 China Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 362 China Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 363 China Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 364 China Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 365 China Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 366 China Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 367 China Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 368 China Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 369 China Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 370 China Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 371 China Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 372 Japan Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 373 Japan Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 374 Japan Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 375 Japan Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 376 Japan Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 377 Japan Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 378 Japan Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 379 Japan Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 380 Japan Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 381 Japan Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 382 Japan Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 383 Japan Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 384 India Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 385 India Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 386 India Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 387 India Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 388 India Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 389 India Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 390 India Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 391 India Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 392 India Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 393 India Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 394 India Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 395 India Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 396 South Korea Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 397 South Korea Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 398 South Korea Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 399 South Korea Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 400 South Korea Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 401 South Korea Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 402 South Korea Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 403 South Korea Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 404 South Korea Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 405 South Korea Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 406 South Korea Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 407 South Korea Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 408 Singapore Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 409 Singapore Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 410 Singapore Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 411 Singapore Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 412 Singapore Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 413 Singapore Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 414 Singapore Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 415 Singapore Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 416 Singapore Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 417 Singapore Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 418 Singapore Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 419 Singapore Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 420 Malaysia Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 421 Malaysia Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 422 Malaysia Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 423 Malaysia Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 424 Malaysia Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 425 Malaysia Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 426 Malaysia Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 427 Malaysia Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 428 Malaysia Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 429 Malaysia Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 430 Malaysia Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 431 Malaysia Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 432 Rest of Asia Pacific Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 433 Rest of Asia Pacific Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 434 Rest of Asia Pacific Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 435 Rest of Asia Pacific Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 436 Rest of Asia Pacific Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 437 Rest of Asia Pacific Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 438 Rest of Asia Pacific Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 439 Rest of Asia Pacific Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 440 Rest of Asia Pacific Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 441 Rest of Asia Pacific Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 442 Rest of Asia Pacific Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 443 Rest of Asia Pacific Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 444 LAMEA Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 445 LAMEA Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 446 LAMEA Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 447 LAMEA Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 448 LAMEA Innovative Market by Country, 2018 - 2021, USD Million
  • TABLE 449 LAMEA Innovative Market by Country, 2022 - 2028, USD Million
  • TABLE 450 LAMEA Generic Market by Country, 2018 - 2021, USD Million
  • TABLE 451 LAMEA Generic Market by Country, 2022 - 2028, USD Million
  • TABLE 452 LAMEA Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 453 LAMEA Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 454 LAMEA Parenteral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 455 LAMEA Parenteral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 456 LAMEA Pulmonary Market by Country, 2018 - 2021, USD Million
  • TABLE 457 LAMEA Pulmonary Market by Country, 2022 - 2028, USD Million
  • TABLE 458 LAMEA Mucosal Market by Country, 2018 - 2021, USD Million
  • TABLE 459 LAMEA Mucosal Market by Country, 2022 - 2028, USD Million
  • TABLE 460 LAMEA Oral Route Market by Country, 2018 - 2021, USD Million
  • TABLE 461 LAMEA Oral Route Market by Country, 2022 - 2028, USD Million
  • TABLE 462 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 463 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 464 LAMEA Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 465 LAMEA Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 466 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 467 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 468 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
  • TABLE 469 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
  • TABLE 470 LAMEA Hybrid Technology Market by Country, 2018 - 2021, USD Million
  • TABLE 471 LAMEA Hybrid Technology Market by Country, 2022 - 2028, USD Million
  • TABLE 472 LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 473 LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 474 LAMEA In-house Market by Country, 2018 - 2021, USD Million
  • TABLE 475 LAMEA In-house Market by Country, 2022 - 2028, USD Million
  • TABLE 476 LAMEA Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 477 LAMEA Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 478 LAMEA Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 479 LAMEA Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 480 LAMEA Metabolic Market by Country, 2018 - 2021, USD Million
  • TABLE 481 LAMEA Metabolic Market by Country, 2022 - 2028, USD Million
  • TABLE 482 LAMEA Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 483 LAMEA Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 484 LAMEA GIT & Renal Market by Country, 2018 - 2021, USD Million
  • TABLE 485 LAMEA GIT & Renal Market by Country, 2022 - 2028, USD Million
  • TABLE 486 LAMEA Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
  • TABLE 487 LAMEA Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
  • TABLE 488 LAMEA Respiratory Market by Country, 2018 - 2021, USD Million
  • TABLE 489 LAMEA Respiratory Market by Country, 2022 - 2028, USD Million
  • TABLE 490 LAMEA Central Nervous System Market by Country, 2018 - 2021, USD Million
  • TABLE 491 LAMEA Central Nervous System Market by Country, 2022 - 2028, USD Million
  • TABLE 492 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 493 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 494 LAMEA Pain Market by Country, 2018 - 2021, USD Million
  • TABLE 495 LAMEA Pain Market by Country, 2022 - 2028, USD Million
  • TABLE 496 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 497 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 498 LAMEA Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 499 LAMEA Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 500 Brazil Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 501 Brazil Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 502 Brazil Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 503 Brazil Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 504 Brazil Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 505 Brazil Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 506 Brazil Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 507 Brazil Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 508 Brazil Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 509 Brazil Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 510 Brazil Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 511 Brazil Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 512 Argentina Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 513 Argentina Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 514 Argentina Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 515 Argentina Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 516 Argentina Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 517 Argentina Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 518 Argentina Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 519 Argentina Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 520 Argentina Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 521 Argentina Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 522 Argentina Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 523 Argentina Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 524 UAE Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 525 UAE Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 526 UAE Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 527 UAE Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 528 UAE Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 529 UAE Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 530 UAE Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 531 UAE Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 532 UAE Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 533 UAE Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 534 UAE Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 535 UAE Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 536 Saudi Arabia Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 537 Saudi Arabia Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 538 Saudi Arabia Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 539 Saudi Arabia Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 540 Saudi Arabia Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 541 Saudi Arabia Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 542 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 543 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 544 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 545 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 546 Saudi Arabia Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 547 Saudi Arabia Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 548 South Africa Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 549 South Africa Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 550 South Africa Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 551 South Africa Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 552 South Africa Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 553 South Africa Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 554 South Africa Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 555 South Africa Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 556 South Africa Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 557 South Africa Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 558 South Africa Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 559 South Africa Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 560 Nigeria Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 561 Nigeria Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 562 Nigeria Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 563 Nigeria Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 564 Nigeria Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 565 Nigeria Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 566 Nigeria Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 567 Nigeria Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 568 Nigeria Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 569 Nigeria Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 570 Nigeria Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 571 Nigeria Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 572 Rest of LAMEA Peptide Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 573 Rest of LAMEA Peptide Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 574 Rest of LAMEA Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 575 Rest of LAMEA Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 576 Rest of LAMEA Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 577 Rest of LAMEA Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 578 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
  • TABLE 579 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
  • TABLE 580 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
  • TABLE 581 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
  • TABLE 582 Rest of LAMEA Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 583 Rest of LAMEA Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 584 Key Information - Eli Lilly And Company
  • TABLE 585 KEY INFORMATION - ASTRAZENECA PLC
  • TABLE 586 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 587 Key Information - Novartis AG
  • TABLE 588 Key Information - Pfizer, Inc.
  • TABLE 589 Key Information - Sanofi S.A.
  • TABLE 590 Key Information - GlaxoSmithKline PLC
  • TABLE 591 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 592 Key Information - Lonza Group AG
  • TABLE 593 Key Information - Amgen, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Global Peptide Therapeutics Market share by Type, 2021
  • FIG 5 Global Peptide Therapeutics Market share by Type, 2028
  • FIG 6 Global Peptide Therapeutics Market by Type, 2018 - 2028, USD Million
  • FIG 7 Global Peptide Therapeutics Market share by Route of Administration, 2021
  • FIG 8 Global Peptide Therapeutics Market share by Route of Administration, 2028
  • FIG 9 Global Peptide Therapeutics Market by Route of Administration, 2018 - 2028, USD Million
  • FIG 10 Global Peptide Therapeutics Market share by Synthesis Technology, 2021
  • FIG 11 Global Peptide Therapeutics Market share by Synthesis Technology, 2028
  • FIG 12 Global Peptide Therapeutics Market by Synthesis Technology, 2018 - 2028, USD Million
  • FIG 13 Global Peptide Therapeutics Market share by Type of Manufacturers, 2021
  • FIG 14 Global Peptide Therapeutics Market share by Type of Manufacturers, 2028
  • FIG 15 Global Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2028, USD Million
  • FIG 16 Global Peptide Therapeutics Market share by Application, 2021
  • FIG 17 Global Peptide Therapeutics Market share by Application, 2028
  • FIG 18 Global Peptide Therapeutics Market by Application, 2018 - 2028, USD Million
  • FIG 19 Global Peptide Therapeutics Market share by Region, 2021
  • FIG 20 Global Peptide Therapeutics Market share by Region, 2028
  • FIG 21 Global Peptide Therapeutics Market by Region, 2018 - 2028, USD Million
  • FIG 22 Recent strategies and developments: Eli Lilly And Company
  • FIG 23 Recent strategies and developments: AstraZeneca PLC
  • FIG 24 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
  • FIG 25 Recent strategies and developments: Novartis AG